LAMEA Artificial Intelligence In Cardiology Market

LAMEA Artificial Intelligence In Cardiology Market Size, Share & Industry Analysis Report By Component, By Application, (Diagnosis, Prediction, Drug Discovery, and Other Application). By Medical Condition (Ischemic Heart Disease /CAD, Cardiac Arrhythmias, Heart Failure, and Other Medical Condition), By Country and Growth Forecast, 2025 - 2032

Report Id: KBV-28158 Publication Date: June-2025 Number of Pages: 150 Report Format: PDF + Excel
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Artificial Intelligence In Cardiology Market, by Component
1.4.2 LAMEA Artificial Intelligence In Cardiology Market, by Application
1.4.3 LAMEA Artificial Intelligence In Cardiology Market, by Medical Condition
1.4.4 LAMEA Artificial Intelligence In Cardiology Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2024
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2021-2025)
4.4.2 Key Strategic Move: (Product Launches and Product Expansions : 2021, Nov – 2025, Apr) Leading Players
4.5 Porter Five Forces Analysis

Chapter 5. Value Chain Analysis of Artificial Intelligence In Cardiology Market
5.1 Research & Development (R&D):
5.2 Data Acquisition & Management:
5.3 Model Development & Training:
5.4 Regulatory Approval & Certification:
5.5 Product Integration & Deployment:
5.6 Marketing & Sales:
5.7 After-Sales Support & Feedback Loop:

Chapter 6. Key Customer Criteria - Artificial Intelligence In Cardiology Market
6.1 Diagnostic Accuracy
6.2 Regulatory Compliance
6.3 Data Privacy and Security
6.4 Integration with Existing Healthcare Systems
6.5 Clinical Validation and Peer-Reviewed Evidence
6.6 Ease of Use and Interface Design
6.7 Real-Time Processing and Speed
6.8 Cost-Effectiveness and Return on Investment (ROI)
6.9 Continuous Learning and Model Updates
6.10. Vendor Support and Training Services

Chapter 7. LAMEA Artificial Intelligence In Cardiology Market by Component
7.1 LAMEA Hardware Market by Country
7.2 LAMEA Software Market by Country
7.3 LAMEA Services Market by Country

Chapter 8. LAMEA Artificial Intelligence In Cardiology Market by Application
8.1 LAMEA Diagnosis Market by Country
8.2 LAMEA Prediction Market by Country
8.3 LAMEA Drug Discovery Market by Country
8.4 LAMEA Other Application Market by Country

Chapter 9. LAMEA Artificial Intelligence In Cardiology Market by Medical Condition
9.1 LAMEA Ischemic Heart Disease /CAD Market by Country
9.2 LAMEA Cardiac Arrhythmias Market by Country
9.3 LAMEA Heart Failure Market by Country
9.4 LAMEA Other Medical Condition Market by Country

Chapter 10. LAMEA Artificial Intelligence In Cardiology Market by Country
10.1 Brazil Artificial Intelligence In Cardiology Market
10.1.1 Brazil Artificial Intelligence In Cardiology Market by Component
10.1.2 Brazil Artificial Intelligence In Cardiology Market by Application
10.1.3 Brazil Artificial Intelligence In Cardiology Market by Medical Condition
10.2 Argentina Artificial Intelligence In Cardiology Market
10.2.1 Argentina Artificial Intelligence In Cardiology Market by Component
10.2.2 Argentina Artificial Intelligence In Cardiology Market by Application
10.2.3 Argentina Artificial Intelligence In Cardiology Market by Medical Condition
10.3 UAE Artificial Intelligence In Cardiology Market
10.3.1 UAE Artificial Intelligence In Cardiology Market by Component
10.3.2 UAE Artificial Intelligence In Cardiology Market by Application
10.3.3 UAE Artificial Intelligence In Cardiology Market by Medical Condition
10.4 Saudi Arabia Artificial Intelligence In Cardiology Market
10.4.1 Saudi Arabia Artificial Intelligence In Cardiology Market by Component
10.4.2 Saudi Arabia Artificial Intelligence In Cardiology Market by Application
10.4.3 Saudi Arabia Artificial Intelligence In Cardiology Market by Medical Condition
10.5 South Africa Artificial Intelligence In Cardiology Market
10.5.1 South Africa Artificial Intelligence In Cardiology Market by Component
10.5.2 South Africa Artificial Intelligence In Cardiology Market by Application
10.5.3 South Africa Artificial Intelligence In Cardiology Market by Medical Condition
10.6 Nigeria Artificial Intelligence In Cardiology Market
10.6.1 Nigeria Artificial Intelligence In Cardiology Market by Component
10.6.2 Nigeria Artificial Intelligence In Cardiology Market by Application
10.6.3 Nigeria Artificial Intelligence In Cardiology Market by Medical Condition
10.7 Rest of LAMEA Artificial Intelligence In Cardiology Market
10.7.1 Rest of LAMEA Artificial Intelligence In Cardiology Market by Component
10.7.2 Rest of LAMEA Artificial Intelligence In Cardiology Market by Application
10.7.3 Rest of LAMEA Artificial Intelligence In Cardiology Market by Medical Condition

Chapter 11. Company Profiles
11.1 IDOVEN S.L.
11.1.1 Company Overview
11.2 Ultromics Ltd.
11.2.1 Company Overview
11.2.2 Recent strategies and developments:
11.2.2.1 Partnerships, Collaborations, and Agreements:
11.2.2.2 Product Launches and Product Expansions:
11.3 CardiAI Inc.
11.3.1 Company Overview
11.4 Tempus AI, Inc.
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Research & Development Expenses
11.4.4 Recent strategies and developments:
11.4.4.1 Product Launches and Product Expansions:
11.4.4.2 Acquisition and Mergers:
11.4.5 SWOT Analysis
11.5 Koninklijke Philips N.V.
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 Recent strategies and developments:
11.5.5.1 Partnerships, Collaborations, and Agreements:
11.5.5.2 Product Launches and Product Expansions:
11.5.5.3 Acquisition and Mergers:
11.5.6 SWOT Analysis
11.6 Cleerly, Inc.
11.6.1 Company Overview
11.6.2 Recent strategies and developments:
11.6.2.1 Partnerships, Collaborations, and Agreements:
11.7 Vista AI, Inc.
11.7.1 Company Overview
11.8 Viz.ai, Inc.
11.8.1 Company Overview
11.8.2 Recent strategies and developments:
11.8.2.1 Partnerships, Collaborations, and Agreements:
11.8.2.2 Product Launches and Product Expansions:
11.9 RSIP Vision Ltd.
11.9.1 Company Overview
11.10. GE HealthCare Technologies, Inc.
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Segmental and Regional Analysis
11.10.4 Research & Development Expenses
11.10.5 Recent strategies and developments:
11.10.5.1 Product Launches and Product Expansions:
11.10.6 SWOT Analysis
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 832-2886

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo